Literature DB >> 225617

B-ETA-Endorphin immunoreactivity in rat and human blood: radioimmunoassay, comparative levels and physiological alterations.

H Akil, S J Watson, J D Barchas, C H Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 225617     DOI： 10.1016/0024-3205(79)90250-9

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  6 in total

1.  Stress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation.

Authors:  J Rossier; E French; C Rivier; T Shibasaki; R Guillemin; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

2.  Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis.

Authors:  X Y Bertagna; W J Stone; W E Nicholson; C D Mount; D N Orth
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

3.  The effect of isoprenaline on plasma concentrations of immunoreactive beta-endorphin and beta-lipotropin in the conscious rat.

Authors:  W Knepel; H Anhut; D Nutto; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

4.  beta-Endorphin: stability, clearance behavior, and entry into the central nervous system after intravenous injection of the tritiated peptide in rats and rabbits.

Authors:  R A Houghten; R W Swann; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

Review 5.  Peptide neuroregulators: the opioid system as a model.

Authors:  J D Barchas; C Evans; G R Elliott; P A Berger
Journal:  Yale J Biol Med       Date:  1985 Nov-Dec

6.  Coordinate, equimolar secretion of smaller peptide products derived from pro-ACTH/endorphin by mouse pituitary tumor cells.

Authors:  R E Mains; B A Eipper
Journal:  J Cell Biol       Date:  1981-04       Impact factor: 10.539
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.